ALLO vs IP · rev $22.0K vs P/E 43, $26.62B cap
Allogene Therapeutics Inc (ALLO) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
IP does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the ALLO and IP stock pages for the full models.
Not investment advice.